COVID-19 increases risks of neurological problems
Persons infected with the COVID-19 virus are at an increased risk of developing neurological conditions in the first year after infection, researchers reported on Sept. 22 in Nature… read more.
Persons infected with the COVID-19 virus are at an increased risk of developing neurological conditions in the first year after infection, researchers reported on Sept. 22 in Nature… read more.
Chlamydia, the leading cause of sexually transmitted bacterial infections, evades detection and elimination inside human cells by use of a cloaking device. But Duke University researchers have grasped… read more.
Current vaccination strategies are unlikely to eliminate measles, according to a new study led by faculty at the University of Georgia. The paper, which published today in The Lancet… read more.
As countries start to scale down their SARS-CoV-2 surveillance efforts, the results highlight the importance of continuing robust surveillance in regions of early spread for providing timely information… read more.
Monkeypox can sometimes lead to neurological complications such as encephalitis (brain inflammation), confusion or seizures, finds a new review of evidence led by a UCL researcher. Several studies… read more.
Results from a small study suggest that the antiviral drug tecovirimat is safe and effective for the treatment of monkeypox. The findings were published on August 26, 2022… read more.
The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster… read more.
Lessons learned from the public health responses to the HIV and COVID-19 pandemics should help guide the response to the current outbreak of monkeypox, National Institutes of Health… read more.
Treatment with dupilumab appears to improve survival rates for patients with moderate to severe COVID-19. Researchers reported these findings on August 16, 2022 in Open Forum of Infectious… read more.
Recent research indicates that during the first year of the COVID-19 pandemic, the proportion of working-aged U.S. adults without health insurance did not change despite increases in unemployment,… read more.
Multiple does of the Bacillus Calmette-Guerin (BCG) vaccine appears to offer patients with type 1 diabetes strong protection against COVID-19, researchers reported on August 15, 2022 in Cell… read more.
Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.